1. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents;Mullican;J. Med. Chem.,1993
2. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities;Boschelli;J. Med. Chem.,1993
3. Substituted thiosemicarbazides and corresponding cyclized 1,3,4-oxadiazoles and their anti-inflammatory activity;Raman;J. Pharm. Sci.,1993
4. Synthesis of some new 1-acylthio-semicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones and their anti-inflammatory activities;Sahin;Arzneim. Forsch./Drug Res.,2001
5. Synthesis of N-(2-naphthyloxyacetyl)thiosemicarbazides and 2-arylamino-5-(2-naphthyloxmethyl)-1,3,4-thiadiazoles/oxadiazoles as oral hypoglycemic agents;Husain;Current Sci.,1986